Top 20 Heart Metabolics investors
The most complete profiles first. Showing 20 of 20.
Ingmar WahlqvistVerified
Venture Capital, Investor · Australia
SeedHealth CareLife ScienceEducationBiotechnologyPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Mara MacdonaldVerified
Venture Capital, Private Equity Firm, Investor · Australia
SeedHealth CareLife ScienceEducationBiotechnologyPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Melissa ByrneVerified
Venture Capital, Investor · Australia
SeedHealth CareLife ScienceEducationBiotechnologyPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Michael BettessVerified
Venture Capital, Private Equity Firm, Investor · Australia
SeedHealth CareLife ScienceBiotechnologyHealth and Hospital ServicesPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Richard GasterVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Darren KellyVerified
Venture Capital · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
David FisherVerified
Venture Capital, Private Equity Firm · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
David PezeshkiVerified
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Stephen ThompsonVerified
Venture Capital · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Aaron Royston, M.D.
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more
Contact details available
Drew Burdon
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Jaume Pons
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
Martijn Kleijwegt
Venture Capital, Private Equity Firm, Investor · Netherlands
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Melissa McBurnie
Venture Capital, Private Equity Firm, Investor · Australia
SeedHealth CareLife ScienceBiotechnologyHealth and Hospital ServicesPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Contact details available
Rudy Dekeyser
Venture Capital, Private Equity Firm, Investor · Belgium
Series BHealth CareHospitalsLife ScienceMobilePortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Vincent Brichard
Private Equity Firm, Investor · Netherlands
SeedHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Yvonne Yamanaka
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
Kerensa Argyriou
Venture Capital · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Contact details available
Leighton Read
Venture Capital, Private Equity Firm · United States
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Contact details available
Merijn Klaassen
Private Equity Firm · Netherlands
Health CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- OccuRx10
- QUE Oncology10
- MecRx10
- Ena Respiratory10
- EBR Systems10
- Myricx Pharma10
- Pharvaris10
- Aravax10
- Signostics10
- MetaBloQ10
- Q-Sera10
Frequently asked questions
How many Heart Metabolics investors are on Angel Roster?
Angel Roster lists 20 Heart Metabolics investors. 9 of them (45%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17) and Private Equity Firms (15). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Heart Metabolics investors invest in?
Among those that list a stage, the most common are Series B (7) and Seed (6).
Where are Heart Metabolics investors based?
Most are based in Australia (9), the United States (6) and the Netherlands (3).
Which companies have Heart Metabolics investors backed?
The most-backed portfolio companies among them are OccuRx (10), QUE Oncology (10), MecRx (10), Ena Respiratory (10) and EBR Systems (10).
How do I contact Heart Metabolics investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.